Scientific
research regarding Omega-3 Fatty Acids and Positive Mood*.
Hamazak T., Thienprasert A., Kheovichai K., Samuhaseneetoo S., Nagasawa T.,
Watanabe S. “The effect of docosahexaenoic acid on aggression in elderly
Thai subjects--a placebo-controlled double-blind study.” Nutr Neurosc
5(1):37-41 (2002).
Adams. P., S. Lawson, A. Sanigorski, and A.J. Sinclair. "Arachidonic acid to
eicosapentaenoic acid ratio in blood correlates positively with clinical
symptoms of depression." Lipids 31:S157-S161 (1996).
Hamazaki, T., S. Sawazaki, T. Nagasawa, Y. Nagao, Y Kanagawa, and K. Yazawa.
"Administration of docosahexaenoic acid influences behavior and plasma
catecholamine levels at time of psychological stress." Lipids
34:S33-S37 (1999).
Hamazaki, T., M. Itomura, S. Sawazaki, and Y. Nagao. "Anti-stress effects of
D. H. A." Biofactors 13:41-45 (2000).
Burgress, J. R., L. Stevens, and L. Peck. "Long-chain polyunsaturated fatty
acids in children with attention-deficit hyperactivity disorder." Am J
Clin Nutr 71:327S-330S (2000).
Hamazaki, T., S. Sawazaki, M. Itomura, E. Asaoka, Y. Nagao, N. Nishimura, K.
Yazawa, T. Kuwamori, and M. Kobayashi. "The effect of docosahexaenoic acid
on aggression in young adults." J Clin Invest 97:1129-1134 (1996).
Hamazaki, T., S. Sawazaki, M. Itomura, Y. Nagao, A. Thienprasert, T.
Nagasawa, and S. Watanabe. "Effect of docosahexaenoic acid on hostility."
World Rev Nutr Diet 88:47-52 (2001).
Maes, M. "Fatty acid composition in major depression: Decreased n-3
fractions in cholesterol esters and increased C20:46/C20:5n3 ratio in
cholester ester and phosopholipds. J Affect Dis 38:35-46 (1996).
Yehuda, S., S. Rabinovitz, R. L. Carasso, and D. I. Mostofsky. "Essential
Fatty acid preparation improves Alzheimer's patients' quality of life."
Int J Neurosci 87:141-149 (1996).
Mills, D. E., K. M. Prkochin, K. A. Harvey, and R. P. Ward. "Dietary fatty
acid supplementation alters stress reactvity and performance in man." J
Human Hypertension 3:111-116 (1989).
Peet, M., J. Brind, C. N. Ramchand, S. Shah, and G. K. Vankar. "Two
double-blind placebo-controlled pilot studies of eicosapentaenoic acid in
the treatment of schizophrenia." Schizophr Res 49:243-251 (2001).
Richardson, A.J., et al. “Red cell and plasma fatty acid changes
accompanying symptom remission in a patient with schizophrenia treated with
eicosapentaenoic acid. “ European Neuropsychopharmacology 10 :189-93
(2000).
Stoll, Andrew L., et al. “Omega 3 fatty acids in bipolar disorder.”
Archives of General Psychiatry 56:407-12 (1999).
Maes, M., A Christophe, J. Delanghe, C. Altamura, H. Neels, and H.Y.
Meltzer. "Lowered omega-3 polyunsaturated fatty acids in serum phospholipids
and cholesterol esters of depressed patients." Psychiatry Res
85:275-291 (1999).
Stoll, A. L., E. Severus, M. P. Freeman, S. Reuter, H. A. Zhoyan, E.
Diamond, K. K. Cress, and L. B. Marangell. "Omega-3 fatty acids in bipolar
depression: A preliminary double-blind placebo-controlled trial." Arch
Gen Psychiatry 56:407-412 (1999).
Voigt, R. G., A. M. Llorente, C. L. Jensen, J. K. Fraley, M.C. Berretta, and
W. C. Heird. "A randomized, double-blind, placebo-controlled trial of
docosahexaenoic acid supplementation in children with
attention-deficit/hyperactivity disorder." J Pediatr 139:189-196
(2001).
